Associate Professor Sandra Turner

Clinical Associate Professor
Medicine, Westmead Clinical School

Telephone 98455200

Map

Selected grants

2013

  • Evaluating the Utility of a Patient Decision Aid for Prospective Participants in the TROG RAVES Prostate Cancer Trial (TROG 08.03); Sundaresan P, Bell M, Kneebone A, Turner S, Butow P; Prostate Cancer Foundation of Australia/Young Investigator Grants.

2011

  • A randomised controlled trial testing a Decision Aid to promote informed consent and recruitment to the TROG RAVES trial of post-prostatectomy radiotherapy; Turner S, Butow P, Juraskova I, Kneebone A, Woo H, Bell M; Royal Australian and New Zealand College of Radiologists/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Turner, S., Shaw, T. (2016). Developing competence in biostatistics and research methodology during medical specialty training. Medical Journal of Australia, 204(2), 54-56e. [More Information]
  • Turner, S., Sundaresan, P., Mann, K., Pryor, D., Gebski, V., Shaw, T. (2016). Engaging Future Clinical Oncology Researchers: An Initiative to Integrate Teaching of Biostatistics and Research Methodology into Specialty Training. Clinical Oncology, 28(5), 306-316. [More Information]
  • Tesson, S., Sundaresan, P., Ager, B., Butow, P., Kneebone, A., Costa, D., Woo, H., Pearse, M., Juraskova, I., Turner, S. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology, 119(1), 84-90. [More Information]
  • van Leeuwen, M., Gurney, H., Turner, J., Turner, S., Pearson, S., Laaksonen, M., Harnett, P., Balakrishnar, B., Sabanathan, D., Vajdic, C. (2016). Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011. Cancer Epidemiology, 43, 15-21. [More Information]
  • Smith, A., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G., Stockler, M., Hovey, E., Stubbs, J., Turner, S., Gurney, H., King, M., et al (2016). The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. Journal of Cancer Survivorship, 10(2), 223-233. [More Information]
  • Turner, S., Eriksen, J., Trotter, T., Verfaillie, C., Benstead, K., Giuliani, M., Poortmans, P., Holt, T., Brennan, S., Potter, R. (2015). Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): Objectives and priorities. Radiotherapy and Oncology, 117(1), 188-192. [More Information]
  • Duchesne, G., Cronje, S., Turner, S. (2015). In reply to Jenkins. World Journal of Gastroenterology, 91(1), 243-243. [More Information]
  • Denham, J., Steigler, A., Joseph, D., Lamb, D., Spry, N., Duchesne, G., Atkinson, C., Matthews, J., Turner, S., Kenny, L., et al (2015). Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 115(3), 301-307. [More Information]
  • Turner, S., Seel, M., Berry, M. (2015). Radiation Oncology Training Program Curriculum developments in Australia and New Zealand: Design, implementation and evaluation - What next? Journal of Medical Imaging and Radiation Oncology, 59(6), 728-735. [More Information]
  • Duchesne, G., Turner, S., Cronje, S. (2014). Around the globe-radiation oncology in Australia. International Journal of Radiation Oncology: Biology Physics, 90(1), 1-6. [More Information]
  • Morris, L., Gorayski, P., Turner, S. (2014). Back pain in a cancer patient: A case study. Australian Family Physician, 43(8), 529-530.
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Fraser-Browne, C., Woo, H. (2014). Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology, 26(6), 348-352. [More Information]
  • Leung, J., Le, H., Turner, S., Munro, P., Vukolova, N. (2014). Faculty of Radiation Oncology 2012 trainee survey: Perspectives on choice of specialty training and future work practice preferences. Journal of Medical Imaging and Radiation Oncology, 58(1), 125-133. [More Information]
  • Thiruthaneeswaran, N., Turner, S., Milross, C., Gogna, K. (2014). Promoting a research culture among junior radiation oncologists: Outcomes from the introduction of the Australian and New Zealand research requirement in training. Clinical Oncology, 26(3), 162-173. [More Information]
  • Foroudi, F., Pham, D., Rolfo, A., Bressel, M., Tang, C., Tan, A., Turner, S., Hruby, G., Williams, S., Hayne, D., et al (2014). The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiotherapy and Oncology, 111(2), 316-320. [More Information]
  • Denham, J., Steigler, A., Tai, K., Joseph, D., Matthews, J., Atkinson, C., Spry, N., Turner, S., North, J., Christie, D., et al (2013). Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer. Radiotherapy and Oncology, 107(2), 123-128. [More Information]
  • Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., et al (2013). The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psycho-Oncology, 22(11), 2557-2564. [More Information]
  • Hindson, B., Turner, S., Millar, J., Foroudi, F., Gogna, N., Skala, M., Kneebone, A., Christie, D., Lehman, M., Wiltshire, K., et al (2012). Australian and New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder. Journal of Medical Imaging and Radiation Oncology, 56(1), 18-30. [More Information]
  • Ng, E., Woo, H., Turner, S., Leong, E., Jackson, M., Spry, N. (2012). The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression. The Journal of Urology, 187(6), 2162-2167. [More Information]
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Butow, P. (2011). Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and Oncology, 101(3), 521-524. [More Information]
  • Denham, J., Steigler, A., Lamb, D., Joseph, D., Turner, S., Matthews, J., Atkinson, C., North, J., Christie, D., Spry, N., et al (2011). Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. The Lancet Oncology, 12(5), 451-459. [More Information]
  • Turner, S., Morgan, G., Palme, C., Veness, M. (2010). Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. Journal of Laryngology and Otology, 124(1), 26-31. [More Information]
  • Graham, P., Capp, A., Delaney, G., Goozee, G., Hickey, B., Turner, S., Browne, L., Milross, C., Wirth, A. (2006). A Pilot Randomised Comparison of Dexamethasone 96 mg vs 16 mg per day for Malignant Spinal-cord Compression Treated by Radiotherapy: TROG 01.05 Superdex Study. Clinical Oncology, 18(1), 70-76. [More Information]
  • Pollicino, C., Turner, S., Roos, D., O'Brien, P. (2005). Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiotherapy and Oncology, 76(3), 264-269. [More Information]
  • Denham, J., Steigler, A., Lamb, D., Joseph, D., Mameghan, H., Turner, S., Matthews, J., Franklin, I., Atkinson, C., North, J., et al (2005). Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. The Lancet Oncology, 6(11), 841-850. [More Information]
  • Kneebone, A., Gebski, V., Hogendoorn, N., Turner, S. (2003). A randomised trial evaluating rigid immobilization for pelvic irradiation. International Journal of Radiation: Oncology - Biology - Physics, 56(4), 1105-1111.
  • Kneebone, A., Turner, S., Berry, M., Vachan, B., Gebski, V. (2003). Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Journal of Medical Imaging and Radiation Oncology, 47(4), 422-427.
  • Turner, S., Gruenewald, S., Spry, N., Gebski, V. (2001). Less pain does equal better quality following stronutium-89 therapy for mestatic prostate cancer. British Journal of Cancer, 24, 5-14.
  • Turner, S., Gruenewald, S., Spry, N., Gebski, V. (2001). Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. British Journal of Cancer, 84(3), 297-302.

Conferences

  • Thompson, S., Turner, S., Gebski, V. (2001). The IPSS: A Better Way of Measuring Urinary Morbidity from Prostate Brachytherapy? Royal Australian & New Zealand College of Radiologists, 52nd Annual Scientific Meeting.

2016

  • Turner, S., Shaw, T. (2016). Developing competence in biostatistics and research methodology during medical specialty training. Medical Journal of Australia, 204(2), 54-56e. [More Information]
  • Turner, S., Sundaresan, P., Mann, K., Pryor, D., Gebski, V., Shaw, T. (2016). Engaging Future Clinical Oncology Researchers: An Initiative to Integrate Teaching of Biostatistics and Research Methodology into Specialty Training. Clinical Oncology, 28(5), 306-316. [More Information]
  • Tesson, S., Sundaresan, P., Ager, B., Butow, P., Kneebone, A., Costa, D., Woo, H., Pearse, M., Juraskova, I., Turner, S. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology, 119(1), 84-90. [More Information]
  • van Leeuwen, M., Gurney, H., Turner, J., Turner, S., Pearson, S., Laaksonen, M., Harnett, P., Balakrishnar, B., Sabanathan, D., Vajdic, C. (2016). Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011. Cancer Epidemiology, 43, 15-21. [More Information]
  • Smith, A., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G., Stockler, M., Hovey, E., Stubbs, J., Turner, S., Gurney, H., King, M., et al (2016). The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. Journal of Cancer Survivorship, 10(2), 223-233. [More Information]

2015

  • Turner, S., Eriksen, J., Trotter, T., Verfaillie, C., Benstead, K., Giuliani, M., Poortmans, P., Holt, T., Brennan, S., Potter, R. (2015). Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): Objectives and priorities. Radiotherapy and Oncology, 117(1), 188-192. [More Information]
  • Duchesne, G., Cronje, S., Turner, S. (2015). In reply to Jenkins. World Journal of Gastroenterology, 91(1), 243-243. [More Information]
  • Denham, J., Steigler, A., Joseph, D., Lamb, D., Spry, N., Duchesne, G., Atkinson, C., Matthews, J., Turner, S., Kenny, L., et al (2015). Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 115(3), 301-307. [More Information]
  • Turner, S., Seel, M., Berry, M. (2015). Radiation Oncology Training Program Curriculum developments in Australia and New Zealand: Design, implementation and evaluation - What next? Journal of Medical Imaging and Radiation Oncology, 59(6), 728-735. [More Information]

2014

  • Duchesne, G., Turner, S., Cronje, S. (2014). Around the globe-radiation oncology in Australia. International Journal of Radiation Oncology: Biology Physics, 90(1), 1-6. [More Information]
  • Morris, L., Gorayski, P., Turner, S. (2014). Back pain in a cancer patient: A case study. Australian Family Physician, 43(8), 529-530.
  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Fraser-Browne, C., Woo, H. (2014). Do Screening Trial Recruitment Logs Accurately Reflect the Eligibility Criteria of a Given Clinical Trial? Early Lessons from the RAVES 0803 Trial. Clinical Oncology, 26(6), 348-352. [More Information]
  • Leung, J., Le, H., Turner, S., Munro, P., Vukolova, N. (2014). Faculty of Radiation Oncology 2012 trainee survey: Perspectives on choice of specialty training and future work practice preferences. Journal of Medical Imaging and Radiation Oncology, 58(1), 125-133. [More Information]
  • Thiruthaneeswaran, N., Turner, S., Milross, C., Gogna, K. (2014). Promoting a research culture among junior radiation oncologists: Outcomes from the introduction of the Australian and New Zealand research requirement in training. Clinical Oncology, 26(3), 162-173. [More Information]
  • Foroudi, F., Pham, D., Rolfo, A., Bressel, M., Tang, C., Tan, A., Turner, S., Hruby, G., Williams, S., Hayne, D., et al (2014). The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiotherapy and Oncology, 111(2), 316-320. [More Information]

2013

  • Denham, J., Steigler, A., Tai, K., Joseph, D., Matthews, J., Atkinson, C., Spry, N., Turner, S., North, J., Christie, D., et al (2013). Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer. Radiotherapy and Oncology, 107(2), 123-128. [More Information]
  • Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., et al (2013). The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psycho-Oncology, 22(11), 2557-2564. [More Information]

2012

  • Hindson, B., Turner, S., Millar, J., Foroudi, F., Gogna, N., Skala, M., Kneebone, A., Christie, D., Lehman, M., Wiltshire, K., et al (2012). Australian and New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder. Journal of Medical Imaging and Radiation Oncology, 56(1), 18-30. [More Information]
  • Ng, E., Woo, H., Turner, S., Leong, E., Jackson, M., Spry, N. (2012). The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression. The Journal of Urology, 187(6), 2162-2167. [More Information]

2011

  • Sundaresan, P., Turner, S., Kneebone, A., Pearse, M., Butow, P. (2011). Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03). Radiotherapy and Oncology, 101(3), 521-524. [More Information]
  • Denham, J., Steigler, A., Lamb, D., Joseph, D., Turner, S., Matthews, J., Atkinson, C., North, J., Christie, D., Spry, N., et al (2011). Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. The Lancet Oncology, 12(5), 451-459. [More Information]

2010

  • Turner, S., Morgan, G., Palme, C., Veness, M. (2010). Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. Journal of Laryngology and Otology, 124(1), 26-31. [More Information]

2006

  • Graham, P., Capp, A., Delaney, G., Goozee, G., Hickey, B., Turner, S., Browne, L., Milross, C., Wirth, A. (2006). A Pilot Randomised Comparison of Dexamethasone 96 mg vs 16 mg per day for Malignant Spinal-cord Compression Treated by Radiotherapy: TROG 01.05 Superdex Study. Clinical Oncology, 18(1), 70-76. [More Information]

2005

  • Pollicino, C., Turner, S., Roos, D., O'Brien, P. (2005). Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiotherapy and Oncology, 76(3), 264-269. [More Information]
  • Denham, J., Steigler, A., Lamb, D., Joseph, D., Mameghan, H., Turner, S., Matthews, J., Franklin, I., Atkinson, C., North, J., et al (2005). Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. The Lancet Oncology, 6(11), 841-850. [More Information]

2003

  • Kneebone, A., Gebski, V., Hogendoorn, N., Turner, S. (2003). A randomised trial evaluating rigid immobilization for pelvic irradiation. International Journal of Radiation: Oncology - Biology - Physics, 56(4), 1105-1111.
  • Kneebone, A., Turner, S., Berry, M., Vachan, B., Gebski, V. (2003). Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Journal of Medical Imaging and Radiation Oncology, 47(4), 422-427.

2001

  • Turner, S., Gruenewald, S., Spry, N., Gebski, V. (2001). Less pain does equal better quality following stronutium-89 therapy for mestatic prostate cancer. British Journal of Cancer, 24, 5-14.
  • Turner, S., Gruenewald, S., Spry, N., Gebski, V. (2001). Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. British Journal of Cancer, 84(3), 297-302.
  • Thompson, S., Turner, S., Gebski, V. (2001). The IPSS: A Better Way of Measuring Urinary Morbidity from Prostate Brachytherapy? Royal Australian & New Zealand College of Radiologists, 52nd Annual Scientific Meeting.

To update your profile click here. For support on your academic profile contact .